Back to all papers

MTL-LymphNet: A Lightweight Multi-Task Learning Framework for Simultaneous Lymph Node Segmentation and Metastasis Classification in Thyroid Cancer Ultrasound.

October 18, 2026pubmed logopapers

Authors

Thahiruddin M,Wahyudi I,Mustofa AN

Affiliations (2)

  • Department of Artificial Intelligence, Universitas Annuqayah, Sumenep, Jawa Timur, Indonesia.
  • Department of Mathematics, Universitas Annuqayah, Sumenep, Jawa Timur, Indonesia.

Abstract

Ultrasound assessment of cervical lymph node metastasis in papillary thyroid carcinoma is crucial but suffers from inter-observer variability. Existing deep learning solutions typically use separate single-task pipelines, resulting in parameter redundancy. We propose MTL-LymphNet, a lightweight, backbone-agnostic multi-task learning framework that simultaneously segments lymph nodes and classifies metastasis within a single forward pass, evaluated across 3 backbones and 4 loss weighting strategies. On 338 images from 2 independent clinical centers, MTL-LymphNet achieved an internal cross-validation Dice coefficient of 0.891 ± 0.022 and AUC of 0.948 ± 0.027. Bidirectional external validation revealed substantial domain shift, with cross-center Dice of 0.865 and 0.779, and AUC of 0.733 and 0.830. The multi-task configuration offered a favorable efficiency-performance trade-off (∆Dice = <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>Δ</mi></mrow></math>, <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo>-</mo><mn>0</mn><mo>.</mo><mn>014</mn></mrow></math>, P < .0001) for 40% fewer parameters than separate models. No backbone or weighting strategy consistently dominated, and calibration degraded substantially under domain shift (ECE: 0.049 internally vs 0.178-0.304 externally), requiring center-specific recalibration before clinical use. To our knowledge, this is the first MTL framework for cervical lymph node analysis with bidirectional multi-center validation and systematic ablation. With a compact size of 22.6 to 29.1 MB and CPU inference of 81 to 131 ms, MTL-LymphNet demonstrates technical feasibility as a CAD tool warranting prospective validation.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.